ArticleScientific reports2025
Increased risk of atrial fibrillation in uterine fibroid patients: a nationwide population-based study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Multi-omics Approaches for Biomarker Discovery of Uterine Fibroids: A Systematic Review.Advances in therapy · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The association between atrial fibrillation (AF) and uterine fibroids (UF) is unclear, though UF are linked to an elevated risk of cardiovascular disease. This study aimed to investigate the AF risk in UF patients. Females aged 20-39 who received health examinations from 2009 to 2012 were included. UF were defined using the ICD-10 codes, and surgical treatment status was defined by procedural codes. The primary outcome was incident AF, evaluated using a Cox regression model, which also assessed AF risk according to surgical treatment status. Among 2,574,349 participants (UF 20,682 [0.8%], mean age 29.8 ± 4.3 years, mean follow-up duration 7.3 ± 1.1 years), 3,868 patients developed AF (n = 61, UF; n = 3,807, control). AF incidence was higher in the UF group than the control (0.41 and 0.20 per 1,000 person-years, respectively). Multivariate Cox-regression analysis identified UF as an independent risk factor for AF (aHR 1.50, 95% CI 1.16-1.93, p = 0.002). Compared to the control group, UF group with surgery had similar AF risk (aHR 1.22, 95% CI 0.79-1.90), however, those without surgery had higher AF risk (aHR 1.69, 95% CI 1.24-2.30). UF patients were associated with increased risk of AF. Careful monitoring of arrhythmia development is warranted in women with UF.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.